Uniqure B.V. buy melinda
Start price
29.08.20
/
50%
€32.45
Target price
04.11.21
€40.00
Performance (%)
-7.18%
End price
05.11.21
€30.12
Summary
This prediction ended on 05.11.21 with a price of €30.12. With a performance of -7.18%, the BUY prediction by melinda finished with a loss. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Uniqure B.V. | -7.734% | -7.734% | -34.245% | -83.382% |
iShares Core DAX® | -3.429% | 3.133% | 15.455% | 14.827% |
iShares Nasdaq 100 | -6.121% | -1.433% | 16.794% | 27.167% |
iShares Nikkei 225® | -7.364% | 1.018% | 8.293% | -2.680% |
iShares S&P 500 | -4.366% | 0.247% | 18.541% | 32.687% |
According to melinda what are the pros and cons of Uniqure B.V. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Uniqure B.V. diskutieren
Buy mit Kursziel 40,0
Uniqure a bénéficé cette semaine d'un interêt particulier pour les biotechs AAV au Nasdaq. En hebdo c'est magnifique à confirmer avec objectif long terme la zone des 50$.....
In the thread Trading Uniqure B.V.
Die von melinda gewählte maximale Laufzeit wurde überschritten
Stopped prediction by melinda for Uniqure B.V.
Uniqure B.V.
Start price
Target price
Perf. (%)
€19.00
27.12.21
27.12.21
-
27.12.22
27.12.22
8.55%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Uniqure B.V.
Start price
Target price
Perf. (%)
€38.10
30.08.18
30.08.18
€40.59
25.02.19
25.02.19
31.53%
25.02.19
25.02.19
Could be worthwhile Investment >10% per year
Uniqure B.V.
Start price
Target price
Perf. (%)
€5.41
27.06.17
27.06.17
€6.13
18.07.17
18.07.17
7.52%
18.07.17
18.07.17
Could be worthwhile Investment >10% per year